Investors & Media

Nov 16, 2018 4:02 PM EST

Copyright Nasdaq. Minimum 15 minutes delayed.

Overview

Corporate Profile

Keryx Biopharmaceuticals consists of a team of approximately 200 committed people working with passion to identify meaningful new medicines to advance the care of people with kidney disease. We have assembled a

Keryx Biopharmaceuticals consists of a team of approximately 200 committed people working with passion to identify meaningful new medicines to advance the care of people with kidney disease. We have assembled a deep concentration of kidney care experts, including nephrologists, renal dieticians, nurses and industry veterans in nephrology.

Keryx established its corporate headquarters in Boston to support the U.S. launch of Auryxia. The science of Auryxia comes from the University of Michigan. Keryx successfully advanced it through clinical development and received FDA approval for Auryxia for two indications.

Patients have been and continue to be at the center of our nearly 20 year corporate history.

Keep Reading
blank image

Corporate Governance

Our executive team embodies our vision for nurturing the development of our medicines and delivering value to our company. Each member brings extensive experience and expertise in the fields of pharmaceuticals, finance, and governance.